Cardiovascular comorbidities in acromegaly
<p><strong>Introduction and purpose:</strong> Acromegaly is a rare disease which occurs with the frequency of 0.2-1.1 cases per 100 000 patients per year. The main cause is the excess level of growth hormone (GH) which stimulates the liver to the insulin-like growth factor type 1 (...
Main Authors: | Katarzyna Laszczak, Sara Moqbil, Sylwiusz Niedobylski, Konrad Warchoł |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2021-08-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/35051 |
Similar Items
-
Bringing Cardiovascular Comorbidities in Acromegaly to an Update. How Should We Diagnose and Manage Them?
by: Ana M. Ramos-Leví, et al.
Published: (2019-03-01) -
Advances in Research on the Cardiovascular Complications of Acromegaly
by: Han Yang, et al.
Published: (2021-04-01) -
Congestive heart failure in acromegaly: A review of 6 cases
by: P Dutta, et al.
Published: (2012-01-01) -
Complications and Comorbidities of Acromegaly—Retrospective Study in Polish Center
by: Małgorzata Rolla, et al.
Published: (2021-03-01) -
THE COMMITTEE OF EXPERTS OF THE RUSSIAN SOCIETY OF CARDIOLOGY (RSC). SECTION OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN. NATIONAL GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES DURING PREGNANCY 2018. NEW REVISION: JULY, 2018 (TEXT IS AVAILABLE IN ELECTRONIC VERSION)
by: Article Editorial
Published: (2018-08-01)